Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | -0.023 | 0.7 |
mRNA | Panobinostat | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.023 | 0.7 |
mRNA | TPCA-1 | GDSC1000 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.052 | 0.7 |
mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | KU-55933 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | PHA-665752 | CCLE | pan-cancer | AAC | -0.019 | 0.7 |
mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |